797 related articles for article (PubMed ID: 20361912)
1. Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study.
Rosa AR; Cruz N; Franco C; Haro JM; Bertsch J; Reed C; Aarre TF; Sanchez-Moreno J; Vieta E
J Clin Psychiatry; 2010 Aug; 71(8):1000-6. PubMed ID: 20361912
[TBL] [Abstract][Full Text] [Related]
2. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
[TBL] [Abstract][Full Text] [Related]
3. Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania.
Tohen M; Vieta E; Gonzalez-Pinto A; Reed C; Lin D;
J Clin Psychiatry; 2010 Mar; 71(3):255-61. PubMed ID: 19709503
[TBL] [Abstract][Full Text] [Related]
4. Functional impairment in patients with mania: baseline results of the EMBLEM study.
Goetz I; Tohen M; Reed C; Lorenzo M; Vieta E;
Bipolar Disord; 2007; 9(1-2):45-52. PubMed ID: 17391349
[TBL] [Abstract][Full Text] [Related]
5. Rapid-cycling bipolar I disorder: course and treatment outcome of a large sample across Europe.
Cruz N; Vieta E; Comes M; Haro JM; Reed C; Bertsch J;
J Psychiatr Res; 2008 Oct; 42(13):1068-75. PubMed ID: 18262204
[TBL] [Abstract][Full Text] [Related]
6. Mania in the Nordic countries: patients and treatment in the acute phase of the EMBLEM study.
Larsen JK; Porsdal V; Aarre TF; Koponen HJ; Aarnio J; Kleivenes OK;
Nord J Psychiatry; 2009; 63(4):285-91. PubMed ID: 19140076
[TBL] [Abstract][Full Text] [Related]
7. Chronic mania revisited: factors associated with treatment non-response during prospective follow-up of a large European cohort (EMBLEM).
Van Riel WG; Vieta E; Martinez-Aran A; Haro JM; Bertsch J; Reed C; Van Os J
World J Biol Psychiatry; 2008; 9(4):313-20. PubMed ID: 18949649
[TBL] [Abstract][Full Text] [Related]
8. Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype.
Geller B; Tillman R; Craney JL; Bolhofner K
Arch Gen Psychiatry; 2004 May; 61(5):459-67. PubMed ID: 15123490
[TBL] [Abstract][Full Text] [Related]
9. Suicidal attempts in bipolar disorder: results from an observational study (EMBLEM).
Bellivier F; Yon L; Luquiens A; Azorin JM; Bertsch J; Gerard S; Reed C; Lukasiewicz M
Bipolar Disord; 2011 Jun; 13(4):377-86. PubMed ID: 21843277
[TBL] [Abstract][Full Text] [Related]
10. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.
McElroy SL; Martens BE; Winstanley EL; Creech R; Malhotra S; Keck PE
J Affect Disord; 2010 Jul; 124(1-2):157-63. PubMed ID: 19963274
[TBL] [Abstract][Full Text] [Related]
11. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
[TBL] [Abstract][Full Text] [Related]
12. The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD.
Schneck CD; Miklowitz DJ; Miyahara S; Araga M; Wisniewski S; Gyulai L; Allen MH; Thase ME; Sachs GS
Am J Psychiatry; 2008 Mar; 165(3):370-7; quiz 410. PubMed ID: 18198271
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
Vieta E; Panicali F; Goetz I; Reed C; Comes M; Tohen M;
J Affect Disord; 2008 Feb; 106(1-2):63-72. PubMed ID: 17582508
[TBL] [Abstract][Full Text] [Related]
14. Observational study designs for bipolar disorder - what can they tell us about treatment in acute mania?
Reed C; Novick D; Gonzalez-Pinto A; Bertsch J; Haro JM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):715-21. PubMed ID: 19345251
[TBL] [Abstract][Full Text] [Related]
15. One-year outcome with antidepressant--treatment of bipolar depression.
Joffe RT; MacQueen GM; Marriott M; Young LT
Acta Psychiatr Scand; 2005 Aug; 112(2):105-9. PubMed ID: 15992391
[TBL] [Abstract][Full Text] [Related]
16. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.
Vieta E; Goikolea JM; Corbella B; Benabarre A; Reinares M; Martínez G; Fernández A; Colom F; Martínez-Arán A; Torrent C;
J Clin Psychiatry; 2001 Oct; 62(10):818-25. PubMed ID: 11816872
[TBL] [Abstract][Full Text] [Related]
17. The management of bipolar mania: a national survey of baseline data from the EMBLEM study in Italy.
Bellantuono C; Barraco A; Rossi A; Goetz I
BMC Psychiatry; 2007 Jul; 7():33. PubMed ID: 17640381
[TBL] [Abstract][Full Text] [Related]
18. Concordance of self-rated and observer-rated dysphoric symptoms in mania.
Cassidy F; Ahearn E; Carroll BJ
J Affect Disord; 2009 Apr; 114(1-3):294-8. PubMed ID: 18684512
[TBL] [Abstract][Full Text] [Related]
19. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
[TBL] [Abstract][Full Text] [Related]
20. Response to ECT in bipolar I, bipolar II and unipolar depression.
Medda P; Perugi G; Zanello S; Ciuffa M; Cassano GB
J Affect Disord; 2009 Nov; 118(1-3):55-9. PubMed ID: 19223079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
